Clinical Trials Update: Oct. 11, 2010
Rosacea Epilepsy Alzheimer's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study will evaluate an investigational topical gel for redness associated with rosacea. To qualify, candidates must be 18 or older and be in good general health.
The research site is in New York City.
This study is for people who have had epileptic episodes. Participants will receive study drug, study-related physical exams, laboratories, and EKGs at no cost, and compensation for time and travel.
The research site is in Houston, Texas.
This study will evaluate weekly injections of a study medication plus nutritional supplements that may help suppress the inflammatory factor implicated in the neuronal degeneration of Alzheimer's disease.
The research site is in Fort Lauderdale, Fla.
Copyright 2010 ClinicalConnection.com. All rights reserved.